BrightSpring Health Services, Inc. (NASAQ:BTSG) is among the Most Volatile Stocks.
On January 27, 2026, TD Cowen upgraded BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s price objective to $46 from $42 while keeping a Buy rating. The firm noted strong specialty generics trends as a driver of ongoing Q4 momentum.
On January 23, 2026, BMO Capital boosted BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s price target from $40 to $46 and maintained its Outperform rating. BMO Capital noted the firm’s competitive stance and solid pharmaceutical ties, which strengthened confidence in the sustainability of growth in its specialty division. The stock’s impressive performance was primarily driven by the acceleration of growth in the specialty area.
Jirsak / shutterstock.com
On February 2, 2026, BTIG elevated BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s price target to $55 from $50 while maintaining a Buy rating. BTIG pointed out the company’s continuous performance over cycles, regarding it as a proven operator in its coverage of Healthcare IT and Digital Health businesses. BTIG acknowledged the stock’s strength and capacity to grow in the face of changing market conditions.
BrightSpring Health Services, Inc. (NASDAQ:BTSG) provides a platform for delivering complementary health care and pharmaceutical solutions. It operates in two segments: Pharmacy Solutions and Provider Services.
While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 20 Best Performing Stocks in 2025 and 12 Best Food Stocks to Buy in 2026.
Disclosure: None.
